Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

GFP-tagged prion protein is correctly localized and functionally active in the brains of transgenic mice.

Barmada S, Piccardo P, Yamaguchi K, Ghetti B, Harris DA.

Neurobiol Dis. 2004 Aug;16(3):527-37.

PMID:
15262264
2.

The role of PrP in health and disease.

Flechsig E, Weissmann C.

Curr Mol Med. 2004 Jun;4(4):337-53. Review.

PMID:
15354865
3.

A transgenic model of a familial prion disease.

Harris DA, Chiesa R, Drisaldi B, Quaglio E, Migheli A, Piccardo P, Ghetti B.

Arch Virol Suppl. 2000;(16):103-12. Review.

PMID:
11214912
4.

Molecular biology of prion protein and its first homologous protein.

Sakaguchi S.

J Med Invest. 2007 Aug;54(3-4):211-23. Review.

5.

Neuroinvasion of prions: insights from mouse models.

Brandner S, Klein MA, Frigg R, Pekarik V, Parizek P, Raeber A, Glatzel M, Schwarz P, Rülicke T, Weissmann C, Aguzzi A.

Exp Physiol. 2000 Nov;85(6):705-12. Review.

PMID:
11187965
6.

Loss of functional prion protein: a role in prion disorders?

Borchelt DR, Sisodia SS.

Chem Biol. 1996 Aug;3(8):619-21. Review.

7.

[Physiopathology and molecular diagnosis for prion diseases].

Katamine S.

Rinsho Byori. 2000 May;48(5):437-41. Review. Japanese.

PMID:
10892292
8.

Prion protein functions and dysfunction in prion diseases.

Sakudo A, Ikuta K.

Curr Med Chem. 2009;16(3):380-9. Review.

PMID:
19149584
9.

Prion protein genes and prion diseases: studies in transgenic mice.

Telling GC.

Neuropathol Appl Neurobiol. 2000 Jun;26(3):209-20. Review.

PMID:
10886679
10.

A murine model of a familial prion disease.

Harris DA, Chiesa R, Drisaldi B, Quaglio E, Migheli A, Piccardo P, Ghetti B.

Clin Lab Med. 2003 Mar;23(1):175-86. Review.

PMID:
12733431
11.

[Prion protein structure and its relationships with pathogenesis].

Muramoto T.

Rinsho Shinkeigaku. 2003 Nov;43(11):813-6. Review. Japanese.

PMID:
15152472
12.

The prion protein family: diversity, rivalry, and dysfunction.

Watts JC, Westaway D.

Biochim Biophys Acta. 2007 Jun;1772(6):654-72. Review.

13.

Transgenic and knockout mice in research on prion diseases.

Raeber AJ, Brandner S, Klein MA, Benninger Y, Musahl C, Frigg R, Roeckl C, Fischer MB, Weissmann C, Aguzzi A.

Brain Pathol. 1998 Oct;8(4):715-33. Review.

PMID:
9804380
14.

Vaccine approaches to prevent and treat prion infection : progress and challenges.

Müller-Schiffmann A, Korth C.

BioDrugs. 2008;22(1):45-52. Review.

PMID:
18215090
15.

New insights into cellular prion protein (PrPc) functions: the "ying and yang" of a relevant protein.

Nicolas O, Gavín R, del Río JA.

Brain Res Rev. 2009 Oct;61(2):170-84. doi: 10.1016/j.brainresrev.2009.06.002. Review.

PMID:
19523487
16.

The role of rafts in the fibrillization and aggregation of prions.

Pinheiro TJ.

Chem Phys Lipids. 2006 Jun;141(1-2):66-71. Review.

PMID:
16647049
17.

Molecular basis of cerebral neurodegeneration in prion diseases.

Tatzelt J, Schätzl HM.

FEBS J. 2007 Feb;274(3):606-11. Review.

18.

Molecular mechanisms of neurotoxicity of pathological prion protein.

Castilla J, Hetz C, Soto C.

Curr Mol Med. 2004 Jun;4(4):397-403. Review.

PMID:
15354870
19.

Aggregation and fibrillization of prions in lipid membranes.

Kazlauskaite J, Pinheiro TJ.

Biochem Soc Symp. 2005;(72):211-22. Review.

PMID:
15649144
20.

Rodent models for prion diseases.

Groschup MH, Buschmann A.

Vet Res. 2008 Jul-Aug;39(4):32. doi: 10.1051/vetres:2008008. Review.

Items per page

Supplemental Content

Support Center